Y-H Im - Div Hematol Med Oncol, Sungkyunkwan Univ

Senologie - Zeitschrift für Mammadiagnostik und -therapieWissenschaftliche Abstracts zur 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V. (DGS) Interdisziplinär. Kommunikativ. Digital (2021)

引用0浏览0引用

Phase III Randomized Study of Taselisib or Placebo with Fulvestrant in Estrogen Receptor-Positive, PIK3CA-mutant, HER2-negative, Advanced Breast Cancer: the SANDPIPER Trial

S. Dent,J. Cortes,Y-H Im,V Dieras,N. Harbeck,I. E. Krop,T. R. Wilson,N. Cui,F. Schimmoller,J. Y. Hsu, J. He,M. De Laurentiis,S. Sousa,P. Drullinsky,W. Jacot

ANNALS OF ONCOLOGYno. 2 (2021): 197-207

引用89浏览0WOS引用

Abstract CT072: Exploration of impact of tumor BRCA zygosity and genomic loss-of-heterozygosity (gLOH) on efficacy in Phase 3 EMBRACA study of talazoparib in patients (pts …

JK Litton,AD Laird,HS Rugo,J Ettl,SA Hurvitz,M Martin,H Roché,YH Im

user-6073b1344c775e0497f43bf9（2020）

引用0浏览0引用

Mutation analysis of circulating tumour DNA from baseline and study discontinuation samples in SANDPIPER, a phase III study of taselisib or placebo with fulvestrant in oestrogen receptor-positive, human epidermal growth factor receptor 2-negative, PIK3CA-mutant advanced breast cancer

W. Jacot,H. M. Savage,S. Dent, J. Cortes,Y-H. Im,V. C. Dieras,N. Harbeck,I. E. Krop,J. Chen, E. Sokol,F. Schimmoller,J. Hsu,M. De Laurentiis,T. R. Wilson

Annals of Oncologyno. SUPnan (2020): S16-S16

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn